SignalXSignalX

BLFS BIOLIFE SOLUTIONS INC

8-K Current Report
Filed: March 2, 2026
Health Care
Electromedical & Electrotherapeutic Apparatus
BIOLIFE SOLUTIONS INC Overview

BIOLIFE SOLUTIONS INC (BLFS) 8-K current report filed with SEC EDGAR on March 2, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

  • Item 7.01: Regulation FD Disclosure

AI Filing Analysis
8-K

Item 7.01 · Regulation FD Disclosure

  • • Reg FD filing signals BioLife (BLFS) is actively communicating strategic/financial updates to the investment community
  • • Investor presentation dated Feb 26, 2026, published March 2, 2026 — full content in Exhibit 99.1 and on IR website
+1 more insights

Other BIOLIFE SOLUTIONS INC 8-K Filings

8-K Feb 26, 2026

Get deeper insights on BIOLIFE SOLUTIONS INC

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.